Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients

被引：6

作者：

Stempel, Jessica M. ^{[1
]}

Farmakiotis, Dimitrios ^{[2
,4
]}

Tarrand, Jeffrey J. ^{[3
]}

Kontoyiannis, Dimitrios P. ^{[2
]}

机构：

[1] Albert Einstein Med Ctr, Dept Internal Med, Philadelphia, PA 19141 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA

[4] Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2016年 / 85卷 / 03期

关键词：

Candida; Candida glabrata; Candidemia; Central line infection; Cancer; NOSOCOMIAL CANDIDEMIA; RISK-FACTORS; EPIDEMIOLOGY; INFECTIONS; MANAGEMENT; RESISTANCE; MORTALITY; LEUKEMIA; TRIALS; ADULTS;

D O I：

10.1016/j.diagmicrobio.2016.04.001

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Among cancer patients with Candida glabrata (the Candida species with the slowest in-vitro growth) fungemia, time-to-positive blood culture reporting (TTR) was shorter in catheter-associated candidemia (mean +/- standard deviation: 67 +/- 35 h) than in candidemia from other sources (79 +/- 31, P<.01). TTR<48 h was 92% specific for catheter-associated C. glabrata fungemia. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：391 / 393

页数：3

共 19 条

[1] Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
Andes, David R.
Safdar, Nasia
Baddley, John W.
Playford, Geoffrey
Reboli, Annette C.
Rex, John H.
Sobel, Jack D.
Pappas, Peter G.
Kullberg, Bart Jan
[J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (08) : 1110 - 1122
[2] Time to blood culture positivity as a marker for catheter-related candidemia
Ben-Ami, Ronen
Weinberger, Miriam
Orni-Wasserlauff, Ruth
Schwartz, David
Itzhaki, Avraham
Lazarovitch, Tzipora
Bash, Edna
Aharoni, Yuval
Moroz, Irina
Giladi, Michael
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (07) : 2222 - 2226
[3] BROSS J, 1989, AM J MED, V87, P614, DOI 10.1016/S0002-9343(89)80392-4
[4] Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients
Cohen, Yves
Karoubi, Philippe
Adrie, Christophe
Gauzit, Remy
Marsepoil, Thierry
Zarka, Daniel
Clec'h, Christophe
[J]. CRITICAL CARE MEDICINE, 2010, 38 (03) : 826 - 830
[5] Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P
Garbino, J
Pittet, D
[J]. LANCET INFECTIOUS DISEASES, 2003, 3 (11) : 685 - 702
[6] Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation
Farmakiotis, Dimitrios
Kyvernitakis, A.
Tarrand, J. J.
Kontoyiannis, D. P.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (01) : 79 - 86
[7] Drug-Resistant Candida glabrata Infection in Cancer Patients
Farmakiotis, Dimitrios
Tarrand, Jeffrey J.
Kontoyiannis, Dimitrios P.
[J]. EMERGING INFECTIOUS DISEASES, 2014, 20 (11) : 1833 - 1840
[8] Efficacy and Tolerability of Micafungin Monotherapy for Candidemia and Deep-Seated Candidiasis in Adults with Cancer
Farmakiotis, Dimitrios
Tarrand, Jeffrey J.
Kontoyiannis, Dimitrios P.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (06) : 3526 - 3529
[9] Time to positive culture and identification for Candida blood stream infections
Fernandez, Julianna
Erstad, Brian L.
Petty, Wanda
Nix, David E.
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (04) : 402 - 407
[10] Attributable mortality of nosocomial candidemia, revisited
Gudlaugsson, O
Gillespie, S
Lee, K
Berg, JV
Hu, JF
Messer, S
Herwaldt, L
Pfaller, M
Diekema, D
[J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) : 1172 - 1177

← 1 2 →